Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRadimed Corporation - Common Stock (NQ:IRMD)

93.76 -4.22 (-4.31%)
Streaming Delayed Price Updated: 2:43 PM EST, Feb 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iRadimed Corporation - Common Stock

< Previous 1 2 3 4 Next >
IRADIMED Corp (NASDAQ:IRMD) Emerges as a Top Quality Stock from the Caviar Cruise Screen ↗
Via Chartmill
News headline image
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRadimed (IRMD) Q3 2025 Earnings Call Transcript ↗
IRadimed (IRMD) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
IRADIMED CORPORATION Named to TIME's List of America's Growth Leaders for 2026
Recognized for Exceptional Revenue Growth, Financial Stability, and Stock Performance 
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For November 3, 2025 ↗
 
Via Benzinga
News headline image
Preview: iRadimed's Earnings ↗
 
Via Benzinga
News headline image
Earnings Preview: iRadimed ↗
Via Benzinga
News headline image
Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216 ↗
Iradimed (IRMD) CEO Sold 5,000 Shares Worth $413,216 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
IRADIMED CORP (NASDAQ:IRMD) Reports Strong Q3 2025 Earnings, Beats Estimates and Raises Guidance ↗
Iradimed (IRMD) beat Q3 2025 earnings and revenue estimates, achieving record sales. The MRI device specialist also raised its full-year 2025 guidance, signaling strong momentum. 
Via Chartmill
Topics Earnings
News headline image
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results
Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance 
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold Third Quarter of 2025 Financial Results Conference Call on November 3, 2025
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For May 5, 2025 ↗
 
Via Benzinga
News headline image
US Market's Undiscovered Gems: Three Promising Stocks Poised for Investor Attention
In a financial landscape often dominated by mega-cap technology giants and established blue-chip companies, astute investors are continuously on the hunt for "undiscovered gems"—smaller, often... 
Via MarketMinute
News headline image
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
Iradimed (IRMD) Q2 Revenue Jumps 14% ↗
Via The Motley Fool
News headline image
IRADIMED CORP (NASDAQ:IRMD) Reports Record Q2 2025 Earnings, Raises Full-Year Guidance Amid Strong Market Rally ↗
IRADIMED CORP (IRMD) reported record Q2 2025 earnings, beating estimates with $20.4M revenue and $0.49 EPS. Shares surged 6.27% pre-market as the company raised full-year guidance. 
Via Chartmill
News headline image
IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025
From iRadimed Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For August 1, 2025 ↗
 
Via Benzinga
News headline image
IRADIMED CORP (NASDAQ:IRMD) – A Quality Stock Worth Considering ↗
IRADIMED CORP (NASDAQ:IRMD) is a financially strong, debt-free company with high profitability and growth potential, making it a compelling choice for quality investors. 
Via Chartmill
News headline image
IRadimed Corp (NASDAQ:IRMD) – A Quality Stock Worth Considering ↗
IRadimed Corp (NASDAQ:IRMD) is a debt-free, high-ROIC medical device company with strong profitability and cash flow, making it a candidate for quality investors. 
Via Chartmill
News headline image
IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System
From iRadimed Corporation
Via GlobeNewswire
News headline image
Why IRADIMED CORP (NASDAQ:IRMD) should be investigated by quality investors. ↗
A fundamental analysis of (NASDAQ:IRMD): Should you consider IRADIMED CORP (NASDAQ:IRMD) for quality investing? 
Via Chartmill
News headline image
IRADIMED CORPORATION Announces First Quarter 2025 Financial Results
From iRadimed Corporation
Via GlobeNewswire
News headline image
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
From iRadimed Corporation
Via GlobeNewswire
News headline image
Intuitive Surgical Gets Rating Upgrade. No. 1 In Its Industry; Profits, Sales Climbing. ↗
Intuitive Surgical, No. 1 stock in its group, has a deep moat around its technology and has sold is robotic surgical systems for 30 years. 
Via Investor's Business Daily
Topics Initial Public Offering
News headline image
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference
From iRadimed Corporation
Via GlobeNewswire
News headline image
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share
From iRadimed Corporation
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.